Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:45 AM
Ignite Modification Date:
2025-12-25 @ 12:45 AM
NCT ID:
NCT02949167
Eligibility Criteria:
Inclusion Criteria:
* Complete remission following primary treatment for loco-regional BC (stage I-II) - No confirmed genetic predisposition to BC
* Female gender
* Performance status ≤3
* Read, understand and speak Danish
* No severe cognitive problems
* No severe psychiatric disease requiring treatment or any substance abuse.
Exclusion Criteria:
* Genetic predisposition for BC
* Patient younger than 40 years of age at diagnosis
* Control after recurrent breast cancer
* Other active cancer except non-melanoma skin cancer
* Severe cognitive problems or dementia
* Severe psychiatric disease requiring treatment, e.g. schizophrenia, alcohol or narcotic dependence
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
40 Years
Study:
NCT02949167
Study Brief:
Protocol Section:
NCT02949167